Brian HicksPosted October 27, 2012
It's time to put fear aside and recapture the heart of the American spirit. It's time to capitalize on all the doom and gloom. After all, every billionaire's fortune has to start somewhere...
Jeff SiegelPosted October 27, 2012
Voiding the second amendment is no laughing matter.
Nick HodgePosted October 26, 2012
If you tangle with Wall Street for all of your financial needs, you'll never get ahead. You've got to do it yourself. All you are to them is a pawn... a fee that funds their salary.
Brian HicksPosted October 26, 2012
In an S&P Capital IQ report, three biotech ETFs took the spotlight...
Christian DeHaemerPosted October 25, 2012
Perhaps because it has to do with the complex world of banking, very few people are talking about it. You won't see it on the national news. But know this: Gold will become a lot dearer over the...
Brian HicksPosted October 25, 2012
Even though Warren Buffett believes the global economy is slowing, he is optimistic about the U.S...
Adam EnglishPosted October 24, 2012
The aftermaths of every market crash in history has one thing in common: Those who prepare themselves ahead of time weather the storm... by investing at the bottom as the dust settles.
Brian HicksPosted October 24, 2012
When Australia lifted a longstanding ban on uranium mining in Queensland, mining companies got a boost...
Christian DeHaemerPosted October 23, 2012
Why we remain long on gold, the risk-reward chain for the yellow metal, and three miners you can buy now and watch take off as gold's price rises and production stalls from their South African...
Brian HicksPosted October 23, 2012
Gold's rally from the QE3 announcement petered out, but the metal posted gains after several days of decline...
Briton RylePosted October 22, 2012
A measly $1,000 investment in this medical company in January 2004 would be worth $2.8 million right now... and that amount could double again in the next few years.
Brian HicksPosted October 22, 2012
Active Biotech's partner Ipsen is beginning trials with a drug previously only used for prostate cancer...